Rockville, MD, United States of America

Jeffrey Levine

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regenxbio Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Levine. Retrieved from https://idiyas.com/inventor/jeffrey-levine-3lzbutbc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey Levine

Introduction

Jeffrey Levine is an accomplished inventor based in Rockville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the production and purification of recombinant Adeno-Associated Virus (rAAV) particles. His work has implications for gene therapy and other medical applications.

Latest Patents

Levine holds 1 patent for his innovative method titled "Anion exchange chromatography for recombinant AAV production." This patent outlines methods for the purification of rAAV particles using anion exchange chromatography, which is crucial for enhancing the efficiency and effectiveness of gene therapy treatments.

Career Highlights

Jeffrey Levine is currently employed at Regenxbio Inc., a company known for its advancements in gene therapy. His role at the company allows him to apply his expertise in biotechnology and contribute to groundbreaking research and development in the field.

Collaborations

Levine collaborates with talented professionals such as Sara Zafar and Claire G Zhang. These collaborations enhance the innovative environment at Regenxbio Inc. and foster the development of new technologies in gene therapy.

Conclusion

Jeffrey Levine's contributions to biotechnology, particularly through his patent on rAAV purification methods, highlight his role as a key innovator in the field. His work at Regenxbio Inc. and collaborations with other professionals further emphasize the importance of teamwork in advancing medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…